RNF128 deficiency in macrophages promotes colonic inflammation by suppressing the autophagic degradation of S100A8
- PMID: 39809743
- PMCID: PMC11733159
- DOI: 10.1038/s41419-025-07338-0
RNF128 deficiency in macrophages promotes colonic inflammation by suppressing the autophagic degradation of S100A8
Abstract
Macrophages play important roles in maintaining intestinal homeostasis and in the pathogenesis of inflammatory bowel diseases (IBDs). However, the underlying mechanisms that govern macrophage-mediated inflammation are still largely unknown. In this study, we report that RNF128 is downregulated in proinflammatory macrophages. RNF128 deficiency leads to elevated levels of effector cytokines in vitro and accelerates the progression of IBD in mouse models. Bone marrow transplantation experiments revealed that RNF128 deficiency in bone marrow cells contributes to the worsening of DSS-induced colitis. Mechanistically, RNF128 interacts with and destabilizes S100A8 by promoting its autophagic degradation, which is mediated by the cargo receptor Tollip. Moreover, the administration of an S100A8 neutralizing antibody mitigated the development of colitis and improved survival in DSS-treated Rnf128-/- mice. Overall, our study underscores the anti-inflammatory role of RNF128 in macrophages during the progression of colitis and highlights the potential of targeting the RNF128-Tollip-S100A8 axis to attenuate intestinal inflammation for the treatment of colitis.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval: All animal interventions were approved by the Animal Ethics Committee of The First Affiliated Hospital of Zhengzhou University, China. Human tissues used in this study was approved by the Human Ethical Committee of the First Affiliated Hospital of Zhengzhou University.
Figures








Similar articles
-
E3 ubiquitin ligase RNF128 attenuates colitis and colorectal tumorigenesis by triggering the degradation of IL-6 receptors.J Adv Res. 2025 Jun;72:107-120. doi: 10.1016/j.jare.2024.06.025. Epub 2024 Jul 2. J Adv Res. 2025. PMID: 38964734 Free PMC article.
-
Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis.Cell Rep. 2018 Sep 18;24(12):3296-3311.e6. doi: 10.1016/j.celrep.2018.08.057. Cell Rep. 2018. PMID: 30232010 Free PMC article.
-
VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy.PLoS Biol. 2025 Feb 3;23(2):e3002961. doi: 10.1371/journal.pbio.3002961. eCollection 2025 Feb. PLoS Biol. 2025. PMID: 39899477 Free PMC article.
-
Macrophage Tim-3 maintains intestinal homeostasis in DSS-induced colitis by suppressing neutrophil necroptosis.Redox Biol. 2024 Apr;70:103072. doi: 10.1016/j.redox.2024.103072. Epub 2024 Feb 2. Redox Biol. 2024. PMID: 38330550 Free PMC article.
-
Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization.Inflamm Res. 2024 Sep;73(9):1493-1510. doi: 10.1007/s00011-024-01910-8. Epub 2024 Jul 10. Inflamm Res. 2024. PMID: 38981913
References
-
- Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20:970–9. - PubMed
-
- Wijnands AM, Penning de Vries BBL, Lutgens M, Bakhshi Z, Al Bakir I, Beaugerie L, et al. Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2024;22:1697–708. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources